Sign Up Today and Learn More About GenMedicn Biopharma Stock
Invest in or calculate the value of your shares in GenMedicn Biopharma or other pre-IPO companies through EquityZen's platform.
GenMedicn Biopharma Stock
GenMedicn is a gene therapy drug development company dedicated to popularizing gene therapy drugs to normalized application scenarios.
About GenMedicn Biopharma Stock
Founded
2018
Industries
Software, Artificial Intelligence, Data and Analytics
GenMedicn Biopharma Management
Leadership team at GenMedicn Biopharma
Founder and Chairman
Tung Wen-chi
Co-Founder
Zhang Yip
Join now and verify your accreditation status to gain access to:
- GenMedicn Biopharma Current Valuation
- GenMedicn Biopharma Stock Price
- GenMedicn Biopharma Management
- Available deals in GenMedicn Biopharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- GenMedicn Biopharma Cap Table and Funding History by Share Class and Liquidity Preferences
- GenMedicn Biopharma Revenue and Financials
- GenMedicn Biopharma Highlights
- GenMedicn Biopharma Business Model
- GenMedicn Biopharma Risk Factors
- GenMedicn Biopharma Research Report from SACRA Research
Trading GenMedicn Biopharma Stock
How to invest in GenMedicn Biopharma stock?
Accredited investors can buy pre-IPO stock in companies like GenMedicn Biopharma through EquityZen funds. These investments are made available by existing GenMedicn Biopharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell GenMedicn Biopharma stock?
Shareholders can sell their GenMedicn Biopharma stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."